We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 21, 2021

Evaluation of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent

Circulation: Cardiovascular Interventions

 

Additional Info

Circulation: Cardiovascular Interventions
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent
Circ Cardiovasc Interv 2021 Mar 01;[EPub Ahead of Print], AJ Kirtane, R Stoler, R Feldman, FJ Neumann, L Boutis, N Tahirkheli, R Toelg, I Othman, B Stein, JW Choi, S Windecker, RW Yeh, HL Dauerman, MJ Price, P Underwood, D Allocco, I Meredith, DJ Kereiakes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading